Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA

FEMS Immunology and Medical Microbiology

Volumn 43, Issue 2, 2005, Pages 155-164

  Shin, Sung Jae ^a   Bae, Jong Lye ^b   Cho, Young Wook ^a   Lee, Deog Yong ^a   Kim, Dae Hyuk ^b   Yang, Moon Sik ^b   Jang, Yong Suk ^b   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Actinobacillus pleuropneumoniae; ApxIIA; Immunogenicity; Oral immunization; Saccharomyces cerevisiae

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; PROTEIN APXIIA; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEEDING; FEMALE; GINSENG; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INTESTINE; LETHAL DOSE; LUNG; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SACCHAROMYCES CEREVISIAE; SEROTYPE; SERUM; SURVIVAL RATE; TIME; VACCINATION; YEAST;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, BACTERIAL; HEMOLYSIN PROTEINS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTESTINES; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; VACCINATION; VACCINES, SYNTHETIC;

EID: 12844252535     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.07.004     Document Type: Article

References (30)

1. J.T. Bosse, H. Janson, B.J. Sheehan, A.J. Beddek, A.N. Rycroft, J.S. Kroll, and P.R. Langford Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection Microb. Infect. 4 2000 225 235
2. J. Frey Virulence in Actinobacillus pleuropneumoniae and RTX toxins Trends Microbiol. 3 1995 257 261
3. J.D. Dubreuil, M. Jacques, K.R. Mittal, and M. Gottschalk Actionbacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity Anim. Health Res. Rev. 1 2000 73 93
4. C. Anderson, A.A. Potter, and G.F. Gerlach Isolation and molecular characterization of spontaneously occurring cytolysin-negative mutants of Actinobacillus pleuropneumoniae serotype 7 Infect. Immun. 59 1991 4110 4116
5. T.E. Fuller, S. Martin, J.F. Teel, G.R. Alaniz, M.J. Kennedy, and D.E. Lowery Identification of Actinobacillus pleuropneumoniae virulence genes using signature-tagged mutagenesis in a swine infection model Microb. Pathog. 29 2000 39 51
6. C.T. Prideaux, C. Lenghaus, J. Krywult, and A.L.M. Hodgson Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon Infect. Immun. 67 1999 1962 1966
7. D. Reimer, J. Frey, R. Jansen, H.P. Veit, and T.J. Inzana Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5 Microb. Pathog. 18 1995 197 209
8. R.I. Tascon, J.A. Vanquez-Boland, C.B. Gutierrez-Martin, I. Rodriguez-Barbosa, and E.F. Rodriguez-Ferri The RTX haemolysin ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis Mol. Microbiol. 14 1994 207 216
9. A. Hensel, L.A. van Leengoed, M. Szostak, H. Windt, H. Weissenbock, N. Stockhofe-Zurwieden, A. Katinger, M. Stadler, M. Ganter, S. Bunka, R. Pabst, and W. Lubitz Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model J. Biotechnol. 44 1996 171 181
10. T.L. Bowersock, W.S.W. Shalaby, M. Levy, M.L. Samuels, R. Lallone, M.R. White, D.L. Borie, J. Lehmeyer, and K. Park Evaluation of an orally administrated vaccine, using hydrogels containing bacterial exotoxins of Pasteurella haemolytica, in cattle Am. J. Vet. Res. 55 1994 502 509
11. P.L. Ogra, H. Faden, and R.C. Welliver Vaccination strategies for mucosal immune responses Clin. Microbiol. Rev. 14 2001 430 445
12. R. Pabst, and R.M. Binns The immune system of the respiratory tract in pigs Vet. Immunol. Immunopathol. 43 1994 151 156
13. D.S. Silin, and V. Lyubomska Overcoming immune tolerance during oral vaccination against Actinobacillus pleuropneumoniae J. Vet. Med. B Infect. Dis. Vet. Public Health 49 2002 169 175
14. G. Dietrich, M. Griot-Wenk, I.C. Metcalfe, A.B. Lang, and J.F. Viret Experience with registered mucosal vaccines Vaccine 21 2003 678 683
15. E. Cox, Y. Van der Stede, F. Verdonck, V. Snoeck, W. Van den Broeck, and B. Goddeeris Oral immunization of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms Vet. Immunol. Immunopathol. 87 2002 287 290
16. T.G. Lauterslager, and L.A. Hilgers Efficacy of oral administration and oral intake of edible vaccines Immunol. Lett. 84 2002 185 190
17. T.G. Lauterslager, W. Stok, and L.A. Hilgers Improvement of the systemic prime/oral boost strategy for systemic and local responses Vaccine 21 2003 1391 1399
18. J.P. Bouvet, N. Decroix, and P. Pamonsinlapatham Stimulation of local antibody production: parenteral or mucosal vaccination? Trends Immunol. 23 2002 209 213
19. I.C. Bathurst Protein expression in yeast as an approach to production of recombinant malaria antigens Am. J. Trop. Med. Hyg. 50 1994 11 19
20. M.P. Schreuder, C. Deen, W.J.A. Boersma, P.H. Pouwels, and F.M. Klis Yeast expressing hepatitis B virus antigen determinants on its surface: implications for a possible oral vaccine Vaccine 14 1996 383 388
21. A.C. Stubbs, K.S. Martin, C. Coeshott, S.V. Skaates, D.R. Kuritzkes, D. Bellgrau, A. Franzusoff, R.C. Duke, and C.C. Wilson Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity Nat. Med. 7 2001 625 629
22. M.P. Schreuder, A.T.A. Mooren, H.Y. Toschka, C. Theo Verrips, and F.M. Klis Immobilizing proteins on the surface of yeast cells Tib. Tech. 14 1996 115 120
23. R. Beier, and A. Gebert Kinetics of particle uptake in the domes of Peyer's patches Am. J. Physio1. 275 1998 130 137
24. S.J. Shin, Y.W. Cho, and H.S. Yoo Cloning, sequencing and expression of apxIA, IIA, IIIA of Actinobacillus pleuropneumoniae isolated in Korea Korean J. Vet. Res. 43 2003 247 253
25. S.J. Shin, J.L. Bae, Y.W. Cho, M.S. Yang, D.H. Kim, Y.S. Jang, and H.S. Yoo Expression of apxIA of Actinobacillus pleuropneumoniae in Saccharomyces cerevisiae J. Vet. Sci. 4 2004 225 228
26. H. Ito, Y. Fukuda, K. Murata, and A. Kimura Transformation of intact yeast cells treated with alkali cations J. Bacteriol. 153 1983 163 168
27. N. Venkatesan, and S.P. Vyas Polysaccharide coated liposomes for oral immunization - development and characterization Int. J. Pharm. 203 2000 169 177
28. K. Chiers, I. van Overbeke, P. De Laender, R. Ducatelle, S. Carel, and F. Haesebrouck Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins Vet. Q. 20 1998 65 69
29. Y. Batard, A. Hehn, S. Nedelkina, M. Schlk, K. Pallett, H. Schaller, and D. Werk-Reichhart Increasing expression of P450 and P450-reductase proteins from monocots in heterologous systems Arch. Biochem. Biophys. 379 2000 161 169
30. I. Van Overbeke, K. Chiers, R. Ducatelle, and F. Haesebrouck Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins J. Vet. Med. B 48 2001 15 20